{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T22:20:13Z","timestamp":1775686813812,"version":"3.50.1"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2018,1,10]],"date-time":"2018-01-10T00:00:00Z","timestamp":1515542400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1007\/s00520-017-4040-x","type":"journal-article","created":{"date-parts":[[2018,1,10]],"date-time":"2018-01-10T03:40:40Z","timestamp":1515555640000},"page":"1979-1983","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Utility of fosfomycin as antibacterial prophylaxis in patients with hematologic malignancies"],"prefix":"10.1007","volume":"26","author":[{"given":"Tanya","family":"Zapolskaya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4502-7579","authenticated-orcid":false,"given":"Sarah","family":"Perreault","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dayna","family":"McManus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey E.","family":"Topal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,1,10]]},"reference":[{"issue":"7","key":"4040_CR1","doi-asserted-by":"publisher","first-page":"882","DOI":"10.6004\/jnccn.2016.0093","volume":"14","author":"LR Baden","year":"2016","unstructured":"Baden LR, Swaminathan S, Angarone M, Blouin G, Camins BC, Casper C, Cooper B, Dubberke ER, Engemann AM, Freifeld AG, Greene JN, Ito JI, Kaul DR, Lustberg ME, Montoya JG, Rolston K, Satyanarayana G, Segal B, Seo SK, Shoham S, Taplitz R, Topal J, Wilson JW, Hoffmann KG, Smith C (2016) Prevention and treatment of cancer-related infections, version 2.2016, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Cancer Netw 14(7):882\u2013813. \n                    https:\/\/doi.org\/10.6004\/jnccn.2016.0093","journal-title":"J Natl Compr Cancer Netw"},{"issue":"4","key":"4040_CR2","doi-asserted-by":"publisher","first-page":"e56","DOI":"10.1093\/cid\/cir073","volume":"52","author":"AG Freifeld","year":"2011","unstructured":"Freifeld AG, Bow EJ, Sepkowitz KA, Boeckh MJ, Ito JI, Mullen CA, Raad II, Rolston KV, Young JA, Wingard JR, Infectious Diseases Society of America (2011) Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america. Clin Infect Dis 52(4):e56\u2013e93. \n                    https:\/\/doi.org\/10.1093\/cid\/cir073","journal-title":"Clin Infect Dis"},{"issue":"10","key":"4040_CR3","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1056\/NEJMoa050078","volume":"353","author":"M Cullen","year":"2005","unstructured":"Cullen M, Steven N, Billingham L, Gaunt C, Hastings M, Simmonds P, Stuart N, Rea D, Bower M, Fernando I, Huddart R, Gollins S, Stanley A, Simple Investigation in Neutropenic Individuals of the Frequency of Infection after Chemotherapy +\/- Antibiotic in a Number of Tumours (SIGNIFICANT) Trial Group (2005) Antibacterial prophylaxis after chemotherapy for solid tumors and lymphomas. N Engl J Med 353(10):988\u2013998. \n                    https:\/\/doi.org\/10.1056\/NEJMoa050078","journal-title":"N Engl J Med"},{"issue":"10","key":"4040_CR4","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1056\/NEJMoa044097","volume":"353","author":"G Bucaneve","year":"2005","unstructured":"Bucaneve G, Micozzi A, Menichetti F, Martino P, Dionisi MS, Martinelli G, Allione B, D\u2019Antonio D, Buelli M, Nosari AM, Cilloni D, Zuffa E, Cantaffa R, Specchia G, Amadori S, Fabbiano F, Deliliers GL, Lauria F, Fo\u00e0 R, Gruppo Italiano Malattie Ematologiche dell\u2019Adulto (GIMEMA) Infection Program (2005) Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia. N Engl J Med 353(10):977\u2013987. \n                    https:\/\/doi.org\/10.1056\/NEJMoa044097","journal-title":"N Engl J Med"},{"issue":"2","key":"4040_CR5","doi-asserted-by":"publisher","first-page":"235","DOI":"10.6004\/jnccn.2007.0023","volume":"5","author":"BH Segal","year":"2007","unstructured":"Segal BH, Freifeld AG (2007) Antibacterial prophylaxis in patients with neutropenia. J Natl Compr Cancer Netw 5(2):235\u2013232. \n                    https:\/\/doi.org\/10.6004\/jnccn.2007.0023","journal-title":"J Natl Compr Cancer Netw"},{"issue":"1","key":"4040_CR6","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1093\/jac\/dkh510","volume":"55","author":"WV Kern","year":"2005","unstructured":"Kern WV, Steib-Bauert M, de With K, Reuter S, Bertz H, Frank U, von Baum H (2005) Fluoroquinolone consumption and resistance in haematology-oncology patients: ecological analysis in two university hospitals, 1999-2002. J Antimicrob Chemother 55(1):57\u201360. \n                    https:\/\/doi.org\/10.1093\/jac\/dkh510","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"4040_CR7","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1002\/cncr.24812","volume":"116","author":"G Rangaraj","year":"2010","unstructured":"Rangaraj G, Granwehr BP, Jiang Y, Hachem R, Raad I (2010) Perils of quinolone exposure in cancer patients: breakthrough bacteremia with multidrug-resistant organisms. Cancer 116(4):967\u2013963. \n                    https:\/\/doi.org\/10.1002\/cncr.24812","journal-title":"Cancer"},{"issue":"8","key":"4040_CR8","doi-asserted-by":"publisher","first-page":"711","DOI":"10.4065\/mcp.2010.0006","volume":"85","author":"BL Therriault","year":"2010","unstructured":"Therriault BL, Wilson JW, Barreto JN, Estes LL (2010) Characterization of bacterial infections in allogeneic hematopoietic stem cell transplant recipients who received prophylactic levofloxacin with either penicillin or doxycycline. Mayo Clin Proc 85(8):711\u2013718. \n                    https:\/\/doi.org\/10.4065\/mcp.2010.0006","journal-title":"Mayo Clin Proc"},{"issue":"9","key":"4040_CR9","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1086\/496986","volume":"41","author":"J Pepin","year":"2005","unstructured":"Pepin J, Saheb N, Coulombe MA, Alary ME, Corriveau MP, Authier S, Leblanc M, Rivard G, Bettez M, Primeau V, Nguyen M, Jacob CE, Lanthier L (2005) Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile associated diarrhea: a cohort study during an epidemic in Quebec. CID 41(9):1254\u20131260. \n                    https:\/\/doi.org\/10.1086\/496986","journal-title":"CID"},{"key":"4040_CR10","first-page":"1579","volume":"16","author":"M Kamboj","year":"2011","unstructured":"Kamboj M, Chung D, Seo SK et al (2011) The changing epidemiology of vancomycin-resistant enterococcus (VRE) bacteremia in allogeneic haematopoietic stem cell transplant (HSCT) recipients. Biol Blood Marrow Transplant 16:1579\u20131571","journal-title":"Biol Blood Marrow Transplant"},{"issue":"8","key":"4040_CR11","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1002\/phar.1434","volume":"34","author":"JL Reffert","year":"2014","unstructured":"Reffert JL, Smith WJ (2014) Fosfomycin for the treatment of resistant Gram negative bacterial infections. Pharmacotherapy 34(8):845\u2013857. \n                    https:\/\/doi.org\/10.1002\/phar.1434","journal-title":"Pharmacotherapy"},{"issue":"5","key":"4040_CR12","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.jiac.2016.01.010","volume":"22","author":"S Sastry","year":"2016","unstructured":"Sastry S, Doi Y (2016) Fosfomycin: resurgence of an old companion. J Infect Chemother 22(5):273\u2013280. \n                    https:\/\/doi.org\/10.1016\/j.jiac.2016.01.010","journal-title":"J Infect Chemother"},{"key":"4040_CR13","doi-asserted-by":"publisher","first-page":"S65","DOI":"10.1007\/BF01643430","volume":"2","author":"T Bergan","year":"1990","unstructured":"Bergan T (1990) Degree of absorption, pharmacokinetics of fosfomycin trometamol and duration of urinary antibacterial activity. Infection 2:S65\u2013S69","journal-title":"Infection"},{"issue":"5","key":"4040_CR14","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1159\/000239140","volume":"39","author":"T Bergan","year":"1993","unstructured":"Bergan T, Thorsteinsson SB, Albini E et al (1993) Pharmacokinetic profile of fosfomycin trometamol. Chemotherapy 39(5):297\u2013291. \n                    https:\/\/doi.org\/10.1159\/000239140","journal-title":"Chemotherapy"},{"issue":"6","key":"4040_CR15","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1016\/j.clinthera.2014.04.013","volume":"36","author":"DJ Wojenski","year":"2014","unstructured":"Wojenski DJ, Barreto JN, Wolf RC, Tosh PK (2014) Cefpodoxime for antimicrobial prophylaxis in neutropenia: a retrospective case series. Clin Ther 36(6):976\u2013981. \n                    https:\/\/doi.org\/10.1016\/j.clinthera.2014.04.013","journal-title":"Clin Ther"},{"issue":"3","key":"4040_CR16","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1177\/1060028014564395","volume":"49","author":"JM Kyle","year":"2015","unstructured":"Kyle JM, Stollings JL, White KD, Noto MJ, Wheeler AP (2015) Fosfomycin for multidrug treatment of Klebsiella pneumoniae carbapenemase bacteremia. Ann Pharmacother 49(3):366\u2013367. \n                    https:\/\/doi.org\/10.1177\/1060028014564395","journal-title":"Ann Pharmacother"},{"issue":"3","key":"4040_CR17","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1128\/AAC.02611-15","volume":"60","author":"I Los-Arcos","year":"2015","unstructured":"Los-Arcos I, Pigrau C, Rodriguez-Pardo D et al (2015) Long term fosfomycin-tromethamine oral therapy for difficult to treat chronic bacterial prostatitis. Antimicrob Agents Chemother 60(3):1854\u20131858. \n                    https:\/\/doi.org\/10.1128\/AAC.02611-15","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"4040_CR18","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1093\/cid\/civ436","volume":"61","author":"ML Grayson","year":"2015","unstructured":"Grayson ML, Macesic N, Trevillyan J, Ellis AG, Zeglinski PT, Hewitt NH, Gardiner BJ, Frauman AG (2015) Fosfomycin for treatment of prostatitis: new tricks for old dogs. CID 61(7):1141\u20131143. \n                    https:\/\/doi.org\/10.1093\/cid\/civ436","journal-title":"CID"},{"issue":"7","key":"4040_CR19","doi-asserted-by":"publisher","first-page":"4398","DOI":"10.1128\/AAC.00447-16","volume":"60","author":"J Aguilar-Company","year":"2016","unstructured":"Aguilar-Company J, Los-Arcos I, Pigrau C, Rodr\u00edguez-Pardo D, Larrosa MN, Rodr\u00edguez-Garrido V, Sihuay-Diburga D, Almirante B (2016) Potential use of fosfomycin-tromethamine for treatment of recurrent Campylobacter species enteritis. Antimicrob Agents Chemother 60(7):4398\u20134400. \n                    https:\/\/doi.org\/10.1128\/AAC.00447-16","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00520-017-4040-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-017-4040-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-017-4040-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,17]],"date-time":"2019-09-17T04:55:48Z","timestamp":1568696148000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00520-017-4040-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,10]]},"references-count":19,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["4040"],"URL":"https:\/\/doi.org\/10.1007\/s00520-017-4040-x","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,10]]},"assertion":[{"value":"29 August 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 December 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"I have no financial relationship with the organization that sponsored the research. I have full control of all primary data and agree to allow the journal to review the data if requested.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}